PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 27(1): 86-89 2007
© 2007 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alhamdani, M.-S. S.
Right arrow Articles by Abbas, F. K.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alhamdani, M.-S. S.
Right arrow Articles by Abbas, F. K.H.

Clinical

DECREASED FORMATION OF ADVANCED GLYCATION END-PRODUCTS IN PERITONEAL FLUID BY CARNOSINE AND RELATED PEPTIDES

Mohamed-Saiel Saeed Alhamdani1, Hasan Fayadh Al-Azzawie2 and Fawzi K.H. Abbas1

1 Department of Medical Sciences, College of Pharmacy, Al-Mustansiriya University;2 Biochemistry Department, College of Science, University of Baghdad, Baghdad, Iraq

Correspondence to: M.S.S. Alhamdani, Department of Medical Sciences, College of Pharmacy, Al-Mustansiriya University, Baghdad, Iraq.
ms.alhamdani{at}gmail.com

{diamondsuit} Background: Formation of advanced glycation end-products (AGEs) is a major problem in uremic patients treated with peritoneal dialysis (PD). Application of additives with known anti-glycosylation properties to PD fluid may be beneficial in minimizing the formation of AGEs. This study aimed to evaluate the effect of carnosine and its related peptides homocarnosine and anserine against the formation of AGEs in PD fluid.

{diamondsuit} Methods: PD solutions (1.5% dextrose) were incubated with human serum albumin (HSA) or collagen (type IV) with or without 10 mmol/L of each of carnosine, anserine, homocarnosine, histidine, and aminoguanidine. The formation of AGEs was followed by fluorescence spectrophotometry at weekly intervals for 7 weeks. For the determination of the acute effect of carnosine and related compounds, HSA and collagen were incubated with 4.25% dextrose PD solutions for 24 hours, followed by incubation with 20 mmol/L of carnosine and related compounds for another 24 hours. The rate of AGE formation was monitored by fluorescence spectrophotometry.

{diamondsuit} Results: Carnosine and related compounds showed effective regression in AGE formation in both types of proteins in both long- and short-term exposure to PD fluids at a rate of effectiveness of the order of carnosine > homocarnosine > anserine, aminoguanidine > histidine in long-term exposure, and homocarnosine > carnosine > aminoguanidine > anserine > histidine in short-term exposure.

{diamondsuit} Conclusion: Carnosine and related peptides could suppress the formation of AGEs initiated by PD fluid. This observation may provide a new therapeutic approach for the prevention and treatment of the AGE-related complications in PD patients.

KEY WORDS: Advanced glycation end-products (AGEs); peritoneal fluid; carnosine; homocarnosine; anserine; aminoguanidine; albumin; collagen.

Received 24 February 2006; accepted 4 August 2006.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2007 by Multimed Inc.